This article was created by StackCommerce. Postmedia may earn an affiliate commission from purchases made through our links ...

From Rihanna to Stefon Diggs, these 2025 fashion icons didn’t just dress well — they defined the culture. Discover the looks ...

The first phase of the military elections is marked by allegations of fraud, electronic voting malfunctions and popular ...

AI is supposed to replace staff and reduce costs. Manuel Hofmann explains why these promises will not save the healthcare ...

UPDF 2.0 introduces an AI assistant, batch tools, and a customizable interface, positioning itself as a cross-platform PDF ...

The Windows search function is also able to include the content of PDF files in its index. Unfortunately, the subsequent ...

Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type ...

Wyatt Reid, of Sidney, Montana, was named to the Fall 2025 Dean's List at the University of Jamestown in Jamestown, North Dakota.

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

National data indicates we may be facing a challenging flu season this year. According to national surveillance, the dominant influenza strain circulating is more infectious than in recent years. It ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.